Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices 53303 

conflict with a fundamental economic 

purpose of ARRA, which is to create or 

retain jobs. 

The Municipal Assistance Unit (CMU) 

has reviewed this waiver request and 

has determined that the supporting 

documentation provided by Sturbridge 

establishes both a proper basis to 

specify a particular manufactured good, 

and that the domestic manufactured 

goods that are currently available do not 

meet the design specifications for the 

proposed project. The information 

provided is sufficient to meet the 

following criteria listed under Section 

1605(b) of the ARRA and in the April 

28, 2009 Memorandum: Iron, steel, and 

the manufactured goods are not 

produced in the United States in 

sufficient and reasonably available 

quantities and of a satisfactory quality. 

The March 31, 2009 Delegation of 

Authority Memorandum provided 

Regional Administrators with temporary 

authority to issue exceptions to Section 

1605 of the ARRA within the geographic 

boundaries of their respective regions 

and with respect to requests by 

individual grant recipients. 

Having established both a proper 

basis to specify the particular good 

required for this project and that this 

manufactured good was not available 

from a producer in the United States, 

the Town of Sturbridge, Massachusetts 

is hereby granted a waiver from the Buy 

American requirements of Section 

1605(a) of Public Law 111–5. This 

waiver permits use of ARRA funds for 

the purchase of a foreign manufactured 

submersible mixer in Sturbridge’s 

waiver request submittal dated May 25, 

2010. This supplementary information 

constitutes the detailed written 

justification required by Section 1605(c) 

for waivers based on a finding under 

subsection (b). 

Authority: Pub. L. 111–5, section 1605. 

Dated: August 19, 2010. 

Ira W. Leighton, 

Acting Regional Administrator, EPA Region 

1—New England. 

[FR Doc. 2010–21676 Filed 8–30–10; 8:45 am] 

BILLING CODE 6560–50–P 

FARM CREDIT ADMINISTRATION 

Farm Credit Administration Board; 

Sunshine Act; Regular Meeting 

AGENCY: Farm Credit Administration. 

SUMMARY: Notice is hereby given, 

pursuant to the Government in the 

Sunshine Act (5 U.S.C. 552b(e)(3)), of 

the regular meeting of the Farm Credit 

Administration Board (Board). 

DATES: Date and Time: The regular 

meeting of the Board will be held at the 

offices of the Farm Credit 

Administration in McLean, Virginia, on 

September 8, 2010, from 9 a.m. until 

such time as the Board concludes its 

business. 

FOR FURTHER INFORMATION CONTACT: 

Roland E. Smith, Secretary to the Farm 

Credit Administration Board, (703) 883– 

4009, TTY (703) 883–4056. 

ADDRESSES: Farm Credit 

Administration, 1501 Farm Credit Drive, 

McLean, Virginia 22102–5090. 

SUPPLEMENTARY INFORMATION: Parts of 

this meeting of the Board will be open 

to the public (limited space available), 

and parts will be closed to the public. 

In order to increase the accessibility to 

Board meetings, persons requiring 

assistance should make arrangements in 

advance. The matters to be considered 

at the meeting are: 

Open Session 

A. Approval of Minutes 

• August 12, 2010. 

B. New Business 

• Merger of the Louisiana Ag Credit 

ACA, and Subsidiaries with Southern 

AgCredit, ACA, and Subsidiaries. 

• Fall 2010 Abstract of the Unified 

Agenda of Federal Regulatory and 

Deregulatory Actions and Fall 2010 

Regulatory Performance Plan. 

• Farm Credit Administration 

Revised FY 2011 and Proposed FY 2012 

Budget. 

Closed Session* 

Reports 

• OSMO Quarterly Report. 

*Session Closed—Exempt pursuant to 

5 U.S.C. 552b(c)(8) and (9). 

Dated: August 27, 2010. 

Roland E. Smith, 

Secretary, Farm Credit Administration Board. 

[FR Doc. 2010–21859 Filed 8–27–10; 4:15 pm] 

BILLING CODE 6705–01–P 

FINANCIAL CRISIS INQUIRY 

COMMISSION 

Notice of Public Hearing 

AGENCY: Financial Crisis Inquiry 

Commission. 

ACTION: Notice. 

SUMMARY: The next public hearing of the 

Financial Crisis Inquiry Commission 

(FCIC) is titled ‘‘Too Big to Fail: 

Expectations and Impact of 

Extraordinary Government Intervention 

and the role of Systemic Risk in the 

Financial Crisis.’’ The forum will also be 

webcast live at http://www.FCIC.gov. 

DATES: The hearing will be held on: 

Wednesday, September 1, 2010, 9 a.m. 

EDT; and Thursday, September 2, 2010, 

9 a.m. EDT. 

ADDRESSES: The hearing will be held at: 

Dirksen Senate Office Building, Room 

538, Washington, DC 20515. 

FOR FURTHER INFORMATION CONTACT: 

Gretchen Kinney Newsom, Financial 

Crisis Inquiry Commission, 1717 

Pennsylvania Avenue, Suite 800, 

Washington, DC 20006. 202–292–2799; 

202–632–1604 fax. 

SUPPLEMENTARY INFORMATION: The 

purpose of the Financial Crisis Inquiry 

Commission is to examine the causes, 

domestic and global, of the current 

financial and economic crisis in the 

United States, per the requirements of 

the Fraud Enforcement and Recovery 

Act of 2009 (‘‘FERA’’), Section 5, Public 

Law 111–21–123 Stat. 1617 (2009). 

Public Participation: The hearing is 

open to the public. The Chairman of the 

Commission will lead the hearing for 

the orderly conduct of business. 

Dated: August 25, 2010. 

Gretchen Kinney Newsom, 

Certifying Official and Special Assistant to 

the Chairman, Financial Crisis Inquiry 

Commission. 

[FR Doc. 2010–21613 Filed 8–30–10; 8:45 am] 

BILLING CODE 6820–RK–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

and the Assistant Secretary for Health 

have taken final action in the following 

case: 

Hung-Shu Chang, PhD, Washington 

State University: Based on the report of 

an investigation conducted by the 

Washington State University (WSU) and 

additional analysis by ORI in its 

oversight review, the U.S. Public Health 

Service (PHS) found that Hung-Shu 

Chang, PhD, former postdoctoral fellow, 

WSU, engaged in research misconduct 

in research supported by National 

Institute of Environmental Health 

Sciences (NIEHS), National Institutes of 

Health (NIH), grant R01 ES012974. 

PHS found that the Respondent 

engaged in scientific (42 CFR 50.102) 

and research misconduct by fabricating 


srobinson on DSKHWCL6B1PROD with NOTICES
53304 Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices 

1Chang, H.S., Anway, M.D., Rekow, S.S., & 

Skinner, M.K. ‘‘Transgenerational epigenetic 

imprinting of the male germline by endocrine 

disruption exposure during gonadal sex 

determination.’’ Endocrinology 147(12):5524–5541; 

hereafter referred to as the ‘‘Endocrinology paper.’’ 

and falsifying data in Figure 3 of a paper 

published in Endocrinology.1

Specifically, PHS found that: 

• Respondent, by not conducting any 

of the claimed bisulfite sequencing, 

fabricated the methylation status of CpG 

sites in eight candidate genes identified 

in both Figures 3 and 4 as No. 11, No. 

12, No. 13, No. 14, 15, No. 22, No. 26, 

No. 31, and No. 19, to support the 

hypothesis that the environmental 

compound, vinclozolin, induces a 

permanent alteration in the epigenetic 

reprogramming of the germline that 

promotes transgenerational disease 

states. 

• Respondent, by conducting only a 

small fraction of the claimed bisulfite 

sequencing, and falsifying the results 

obtained, falsified the methylation 

status of CpG sites in eight additional 

candidate genes, identified in Figures 3 

and 4 as No. 2, 3, 24, No. 5, 6, 9, No. 

8, No. 16, No. 17, 18, No. 27, 28, No. 29, 

and No. 33. 

Dr. Chang has entered into a Voluntary 

Settlement Agreement in which he has 

voluntarily agreed, for a period of three 

(3) years, beginning on July 21, 2010: 

(1) To exclude himself from serving in 

any advisory capacity to PHS, including 

but not limited to service on any PHS 

advisory committee, board, and/or peer 

review committee, or as a consultant; 

(2) that any institution that submits an 

application for PHS support for a 

research project on which the 

Respondent’s participation is proposed 

or that uses him in any capacity on 

PHS-support research, or that submits a 

report of PHS-funded research in which 

the Respondent is involved, must 

concurrently submit a plan for 

supervision of the Respondent’s duties 

to the funding agency for approval. The 

supervisory plan must be designed to 

ensure the scientific integrity of the 

Respondent’s research contribution 

while applying for or conducting PHSsupported research. Respondent agrees 

to ensure that a copy of the supervisory 

plan is submitted to ORI by the 

institution for ORI approval. 

Respondent agrees not to participate in 

any PHS-supported research until such 

a supervisory plan is submitted to ORI. 

FOR FURTHER INFORMATION CONTACT: 

Director, Division of Investigative 

Oversight, Office of Research Integrity, 

1101 Wootton Parkway, Suite 750, 

Rockville, MD 20852, (240) 453–8800. 

John Dahlberg, 

Director, Division of Investigative Oversight, 

Office of Research Integrity. 

[FR Doc. 2010–21579 Filed 8–30–10; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Office of the Assistant Secretary for 

Health; Statement of Organization, 

Functions, and Delegations of 

Authority 

Part A, Office of the Secretary, 

Statement of Organizations, Functions 

and Delegations of Authority for the 

Department of Health and Human 

Services (HHS) is being amended at 

Chapter AA, ‘‘Immediate Office of the 

Secretary,’’ which was last amended at 

75 FR 20364–65, dated April 19, 2010, 

and at Chapter AC, ‘‘Office of Public 

Health and Science (OPHS),’’ which was 

last amended at 72 FR 58095–96, dated 

October 12, 2007. This amendment will 

accomplish two tasks: (1) In Chapter 

AC, revise the title of the office headed 

by the Assistant Secretary for Health 

(ASH) from the ‘‘Office of Public Health 

and Science’’ to the ‘‘Office of the 

Assistant Secretary for Health,’’ and; (2) 

add information about a new office 

reporting to the Assistant Secretary for 

Health (ASH), the ‘‘Office of Adolescent 

Health,’’ established in section 1708 of 

the Public Health Service (PHS) Act (42 

U.S.C. 300u–7), and most recently 

addressed in the December 8, 2009, 

Conference Report (House Report 111– 

366) accompanying the Consolidated 

Appropriations Act, 2010 (Pub. L. 111– 

117). The changes are as follows: 

A. Under Part A, Chapter AA, Section 

AA.10 Organization, replace the ‘‘Office 

of Public Health and Science (AC)’’ with 

the ‘‘Office of the Assistant Secretary for 

Health (AC).’’ 

B. Under Part A generally and Part A, 

Chapter AC, replace all references to the 

‘‘Office of Public Health and Science’’ 

with the ‘‘Office of the Assistant 

Secretary for Health’’ and all references 

to ‘‘OPHS’’ with ‘‘OASH.’’ 

C. Under Part A, Chapter AC, Section 

AC.10 Organization, insert ‘‘M. Office of 

Adolescent Health (ACR)’’ immediately 

after ‘‘L. Office of Commissioned Corps 

Force Management (ACQ).’’ 

D. Under Part A, Chapter AC, Section 

AC.20 Functions, insert the following 

text immediately after item, ‘‘L. Office of 

Commissioned Corps Force 

Management (ACQ)’’: 

M. Office of Adolescent Health (ACR) 

Section ACR.00 Mission. The Director 

of the Office of Adolescent Health 

(OAH) is the principal advisor to the 

Assistant Secretary for Health (ASH) on 

health-related policy and program 

issues related to adolescents. These 

issues cut across Health and Human 

Services (HHS) components which 

provide research, services, prevention, 

promotion, treatment, training, 

education, and information 

dissemination related to adolescent 

health. OAH is responsible for 

implementing activities authorized by 

section 1708 of the Public Health 

Service (PHS) Act. 

Section ACR.10 Organization. The 

Office of Adolescent Health is headed 

by a Director who reports to the 

Assistant Secretary for Health and is 

includes the following components: 

A. Immediate Office of the Director 

(ACR) 

B. Division of Program Development 

and Operations (ACR1) 

C. Division of Policy, Planning, and 

Communications (ACR2) 

Section ACR.20 Functions 

1. Immediate Office of the Director 

(ACR). The Immediate Office of the 

Director (IOD) plans and directs 

financial management and policy 

development, including budget 

formulation and execution. The IOD 

also oversees legislative activities 

related to adolescent health, acts as a 

liaison on personnel management to the 

Office of the Assistant Secretary for 

Health (OASH) and the Program 

Support Center, and coordinates 

correspondence control and executive 

secretariat functions for OAH. The IOD 

also manages the day-to-day operations 

of OAH, plans, coordinates, monitors, 

and evaluates OAH grants and contracts, 

and ensures the appropriate exercise of 

delegated authorities and 

responsibilities. 

2. Division of Program Development 

and Operations (ACR1). The Division of 

Program Development and Operations 

(DPDO) advises the OAH Director on the 

development of new programs and 

policies, oversees the implementation 

and administration of competitive 

grants and cooperative agreements, 

monitors grantee activities, evaluates 

the focus and impact of ongoing 

programs, prepares analytical reports on 

program trends, provides training and 

technical assistance for grant programs, 

and assesses performance of grantee 

operations. The Division manages the 

development of funding announcements 

and contract scopes of work and the 

review and award of program grants, 


srobinson on DSKHWCL6B1PROD with NOTICES